Fox RJ, Coffey CS, Cudkowicz ME, et al. SPRINT-MS/NN 102 phase II trial of ibudilast in progressive MS: top-line results. ECTRIMS 2017, #278.
Langetermijnuitkomsten na behandeling met avalglucosidase alfa
aug 2023 | Neuro-musculair
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen
aug 2021 | Hoofdpijn